Our Roadmap

TeleSync is at the prototype stage. Early conversations with healthcare professionals have confirmed the clinical need, and we have a clear plan for validation, piloting and deployment. This page sets out where we are, where we are going, and what still has to be proven.

Early Validation

4/4 healthcare professionals expressed positive initial acceptance

Preliminary consultation with two doctors and two nurses at a hospital.

  • Clinical need confirmedCurrent telemedicine often lacks objective physical-examination data.
  • Useful clinical informationVital signs and heart and lung sounds were seen as valuable for remote assessment and triage.
  • Implementation potentialUseful for homebound patients, post-discharge monitoring and rural areas.

How we evaluated

  • Concept and workflow presentation
  • Demonstration of proposed device and app functions
  • Semi-structured discussion with healthcare professionals
  • Feedback collected on usefulness, usability, workflow fit and feasibility

Planned quantitative validation

  • Measurement agreement with standard clinical devices
  • Successful device-to-app data transfer
  • User task-completion and error rate
  • Satisfaction scores from patients and healthcare professionals
  • Number of repeat measurements required

Launch Strategy

  • 1
    Completed

    Concept and clinical co-design

    • Identify limitations in current telemedicine
    • Consult healthcare professionals
    • Positive preliminary feedback from two doctors and two nurses
  • 2
    In progress

    Functional prototype

    • Build TeleSync V1
    • Integrate digital stethoscope, SpO₂, heart rate and temperature
    • Test device connectivity and measurement workflow
  • 3
    Planned

    Usability and pilot testing

    • Test with patients, caregivers, nurses and doctors
    • Compare measurements with standard clinical devices
    • Improve the mobile application and doctor dashboard
  • 4
    Planned

    Multi-site deployment

    • Produce approximately 20–50 pilot units
    • Deploy in selected hospitals, clinics, home-care services or emergency teams
    • Establish training, maintenance, cleaning and technical-support procedures
  • 5
    Planned

    Regional and commercial scale

    • Scale through hospital-managed patient rental
    • Provincial deployment in rural clinics
    • Strengthen the telehealth network across regions
Looking further ahead

A professional healthcare model

A later version for nurses, paramedics, doctors, hospitals and emergency-care teams is planned to add:

ECG acquisition and review

Portable ultrasound support

Expanded cardiopulmonary assessment

Multi-patient and multi-device management

Hospital information-system integration

Advanced clinical reporting and referral tools

Deployment Models

B2B2C

Hospital-to-patient rental

Hospitals lend TeleSync to patients and monitor them through the doctor dashboard. Affordable for patients, with no need to buy the device outright.

Who it serves

  • Patients recently discharged from hospital
  • Older adults and homebound patients
  • Patients with chronic cardiopulmonary conditions
  • Patients requiring short-term follow-up
  • Individuals living far from hospitals

Hospital responsibilities

  • Patient selection and device allocation
  • Initial user training
  • Cleaning, disinfection, return and maintenance
B2G

Provincial and rural healthcare

Provincial health authorities deploy TeleSync in rural clinics, linking them to specialist hospitals and improving access in remote and underserved communities.

Where it is deployed

  • Community hospitals
  • Subdistrict health-promoting hospitals
  • Rural health clinics
  • Mobile medical teams
  • Emergency-response units

Public-sector value

  • Reduces unnecessary travel and referrals
  • Supports earlier identification of high-risk patients
  • Extends specialist services to remote communities
Market in Thailand

Who TeleSync can reach

71.7 M Total addressable market

Thailand’s total population and the broad potential market for remote clinical examination.

32.7 M Serviceable addressable market

Rural residents who may benefit most from portable, offline-capable healthcare technology.

150 K Serviceable obtainable market

Examinations per year through a planned initial network of 100 clinics and 500 devices.

Regulatory Pathway

TeleSync is a portable, non-invasive, active telehealth monitoring system. It would likely be classified as a Class 2 medical device under Thailand’s Medical Device Act B.E. 2551, as amended by B.E. 2562, subject to final Thai FDA classification review.

Safety standards

Hardware should align with IEC 60601-1 and IEC 60601-1-2 for safety and electromagnetic compatibility.

Software validation

The mobile app and connected software should follow IEC 62304 software lifecycle principles.

Biocompatibility

Patient-contact materials should be evaluated under ISO 10993 where applicable.

Device classification

Likely an active, non-invasive Class 2 medical device.

Technical dossier

Technical documentation covering intended use, design, labelling, performance and risk management.

Market approval

Product registration and approval would proceed through Thailand’s FDA medical device pathway.

Being clear about where we are

Current Limitations

  • TeleSync is intended to support, not replace, professional medical judgment.
  • Measurement accuracy must be compared with standard medical devices.
  • The prototype has not yet undergone clinical-performance validation.
  • Stakeholder consultation involved only four healthcare professionals.
  • The current findings are qualitative and preliminary.